Our vision is to pursue a life without bleeds for people with haemophilia and to support them along the way to achieving their goals
Our vision is bold and our commitment to it is proven in our continued pursuit to improve the standards of care for haemophilia patients. The journey toward a life without bleeds begins with
Routine prophylaxis has been shown to prevent bleeding and joint deterioration, creating the possibility for patients to pursue the lives they choose. Patients ideally should receive adequate prophylaxis so they are not left at risk for preventable bleeds.
As each patient is unique, there are many factors to consider when personalising prophylaxis, including adherence to therapy, involvement in their own disease management, and dosing needs. There is no "one size fits all" approach to treating individual
patients; care should be personalised.
Shire is built on a legacy of over 60 years of healthcare leadership. We innovate, develop, manufacture, and market treatments to save and sustain patients' lives.
Select from available resources to get information for your practice.
This is an international Web site intended for users outside of the U.S.